scholarly journals Identification of cell-of-origin breast tumor subtypes in inflammatory breast cancer by gene expression profiling

2005 ◽  
Vol 95 (3) ◽  
pp. 243-255 ◽  
Author(s):  
Steven J. Van Laere ◽  
Gert G. Van den Eynden ◽  
Ilse Van der Auwera ◽  
Melanie Vandenberghe ◽  
Peter van Dam ◽  
...  
2004 ◽  
Vol 64 (23) ◽  
pp. 8558-8565 ◽  
Author(s):  
François Bertucci ◽  
Pascal Finetti ◽  
Jacques Rougemont ◽  
Emmanuelle Charafe-Jauffret ◽  
Valéry Nasser ◽  
...  

2005 ◽  
Vol 65 (6) ◽  
pp. 2170-2178 ◽  
Author(s):  
François Bertucci ◽  
Pascal Finetti ◽  
Jacques Rougemont ◽  
Emmanuelle Charafe-Jauffret ◽  
Nathalie Cervera ◽  
...  

2006 ◽  
Vol 9 (1) ◽  
pp. 1-3
Author(s):  
P. E. Lønning

Citation of original article:F. Bertucci, P. Finetti, J. Rougemont, E. Charafe-Jauffret, N. Cervera, C. Tarpin,et al. Gene expression profiling identifies molecular subtypes of inflammatory breast cancer.Cancer Research2005;65(6): 2170–8.Abstract of the original articleBreast cancer is a heterogeneous disease. Comprehensive gene expression profiles obtained using DNA microarrays have revealed previously indistinguishable subtypes of non-inflammatory breast cancer (NIBC) related to different features of mammary epithelial biology and significantly associated with survival. Inflammatory breast cancer (IBC) is a rare, particular, and aggressive form of disease. Here we have investigated whether the five molecular subtypes described for NIBC (luminal A and B, basal, ERBB2 overexpressing, and normal breast-like) were also present in IBC. We monitored the RNA expression of approximately 8,000 genes in 83 breast tissue samples including 37 IBC, 44 NIBC, and 2 normal breast samples. Hierarchical clustering identified the five subtypes of breast cancer in both NIBC and IBC samples. These subtypes were highly similar to those defined in previous studies and associated with similar histoclinical features. The robustness of this classification was confirmed by the use of both alternative gene set and analysis method, and the results were corroborated at the protein level. Furthermore, we show that the differences in gene expression between NIBC and IBC and between IBC with and without pathologic complete response that we have recently reported persist in each subtype. Our results show that the expression signatures defining molecular subtypes of NIBC are also present in IBC. Obtained using different patient series and different microarray platforms, they reinforce confidence in the expression-based molecular taxonomy but also give evidence for its universality in breast cancer, independently of a specific clinical form.


Cancer ◽  
2010 ◽  
Vol 116 (S11) ◽  
pp. 2783-2793 ◽  
Author(s):  
François Bertucci ◽  
Pascal Finetti ◽  
Daniel Birnbaum ◽  
Patrice Viens

PLoS ONE ◽  
2014 ◽  
Vol 9 (10) ◽  
pp. e109742 ◽  
Author(s):  
Fengliang Wang ◽  
Sheng Gao ◽  
Fei Chen ◽  
Ziyi Fu ◽  
Hong Yin ◽  
...  

2005 ◽  
Vol 7 (6) ◽  
pp. 380-389 ◽  
Author(s):  
Nina Oestreicher ◽  
Scott D Ramsey ◽  
Hannah M Linden ◽  
Jeannine S McCune ◽  
Laura J van't Veer ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document